Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,345 | 232 | 98.1% |
| Education | $104.64 | 17 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,741 | 80 | $0 (2021) |
| Allergan Inc. | $646.95 | 23 | $0 (2019) |
| Amarin Pharma Inc. | $609.73 | 29 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $403.96 | 22 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $250.48 | 12 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $241.36 | 9 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $217.22 | 8 | $0 (2021) |
| IRONWOOD PHARMACEUTICALS, INC | $142.41 | 5 | $0 (2020) |
| Synergy Pharmaceuticals Inc | $127.76 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $124.98 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $92.66 | 1 | AIMMUNE THERAPEUTICS, INC. ($92.66) |
| 2021 | $743.79 | 51 | Amgen Inc. ($284.47) |
| 2020 | $632.84 | 28 | Amgen Inc. ($241.24) |
| 2019 | $1,556 | 77 | Amarin Pharma Inc. ($465.96) |
| 2018 | $888.28 | 50 | Allergan Inc. ($266.59) |
| 2017 | $1,536 | 42 | Amgen Inc. ($633.22) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $92.66 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/16/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $13.70 | General |
| Category: Cardiovascular | ||||||
| 12/09/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: Cardiology | ||||||
| 12/01/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Obesity | ||||||
| 11/18/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $14.15 | General |
| Category: Cardiovascular | ||||||
| 11/17/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: VACCINES | ||||||
| 11/11/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $78.95 | General |
| Category: Gastroenterology | ||||||
| 11/11/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: Cardiology | ||||||
| 11/03/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $13.82 | General |
| Category: Cardiovascular | ||||||
| 11/03/2021 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Cardiology | ||||||
| 09/27/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Bone Health | ||||||
| 09/10/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Cardiovascular | ||||||
| 09/09/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $13.48 | General |
| Category: Cardiovascular | ||||||
| 09/03/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.64 | General |
| Category: Neuroscience | ||||||
| 09/02/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Obesity | ||||||
| 08/31/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/30/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/19/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiology | ||||||
| 08/05/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology | ||||||
| 07/30/2021 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/23/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/22/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/21/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Bone Health | ||||||
| 07/15/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 40 | 4,957 | 6,453 | $259,430 | $207,249 |
| 2020 | 47 | 7,083 | 10,687 | $309,294 | $238,818 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 274 | 532 | $79,530 | $56,346 | 70.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 234 | 234 | $34,900 | $34,740 | 99.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 221 | 408 | $43,381 | $26,927 | 62.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 99 | 100 | $9,646 | $8,804 | 91.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 30 | 33 | $7,718 | $6,161 | 79.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2021 | 187 | 187 | $5,526 | $5,491 | 99.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 235 | 235 | $5,179 | $5,047 | 97.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 223 | 223 | $4,894 | $4,789 | 97.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 29 | $6,040 | $4,405 | 72.9% |
| 82306 | Vitamin d-3 level | Office | 2021 | 140 | 146 | $4,594 | $4,322 | 94.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 222 | 280 | $4,122 | $3,749 | 91.0% |
| 93922 | Ultrasound study of arteries of both arms and legs, limited | Office | 2021 | 51 | 51 | $5,926 | $3,705 | 62.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 241 | 267 | $5,209 | $3,137 | 60.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 154 | 174 | $3,152 | $2,923 | 92.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 223 | 295 | $3,006 | $2,864 | 95.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 229 | 319 | $2,914 | $2,699 | 92.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 14 | 14 | $2,660 | $2,638 | 99.2% |
| 80076 | Liver function blood test panel | Office | 2021 | 229 | 315 | $2,742 | $2,574 | 93.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 226 | 319 | $2,616 | $2,479 | 94.7% |
| 83090 | Homocysteine (amino acid) level | Office | 2021 | 133 | 133 | $2,486 | $2,383 | 95.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 297 | 767 | $2,613 | $2,292 | 87.7% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2021 | 229 | 315 | $2,396 | $2,268 | 94.7% |
| 77085 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine), including assessment of vertebral fracture | Office | 2021 | 35 | 35 | $2,492 | $2,179 | 87.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2021 | 140 | 144 | $2,291 | $2,172 | 94.8% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 136 | 138 | $2,159 | $1,881 | 87.1% |
About Dr. Jeffrey Lefkowitz, MD
Dr. Jeffrey Lefkowitz, MD is a Gastroenterology healthcare provider based in Fair Lawn, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790757870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Lefkowitz, MD has received a total of $5,449 in payments from pharmaceutical and medical device companies, with $92.66 received in 2024. These payments were reported across 249 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,345).
As a Medicare-enrolled provider, Lefkowitz has provided services to 12,040 Medicare beneficiaries, totaling 17,140 services with total Medicare billing of $446,067. Data is available for 2 years (2020–2021), covering 87 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Fair Lawn, NJ
- Active Since 02/03/2006
- Last Updated 09/08/2008
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1790757870
Products in Payments
- Repatha (Biological) $811.47
- Vascepa (Drug) $609.73
- LINZESS (Drug) $608.57
- Prolia (Biological) $417.81
- Livalo (Drug) $403.96
- EVENITY (Biological) $266.93
- XIFAXAN (Drug) $201.49
- TRULANCE (Drug) $142.18
- Aimovig (Biological) $130.63
- Linzess (Drug) $130.60
- Trulance (Drug) $127.76
- FARXIGA (Drug) $124.98
- SOLIQUA 100/33 (Drug) $124.85
- BELSOMRA (Drug) $115.21
- ZENPEP (Drug) $103.26
- JANUVIA (Drug) $87.95
- MOVIPREP (Drug) $66.48
- NEXLETOL (Drug) $63.09
- VIBERZI (Drug) $53.78
- PRADAXA (Drug) $51.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fair Lawn
Dr. Ramesh Gupta, M.d, M.D
Gastroenterology — Payments: $170,465
Gary Gorodokin, Md, MD
Gastroenterology — Payments: $15,864
Dr. Donald Kutner, Do, DO
Gastroenterology — Payments: $6,549
Dr. Jonathan Resnick, Md, MD
Gastroenterology — Payments: $3,830
Youssef Botros
Gastroenterology — Payments: $2,817
Kuchipudi Bapineedu, Md, MD
Gastroenterology — Payments: $674.39